Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 27;62:102123. doi: 10.1016/j.eclinm.2023.102123

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 5 — Comparison of expression of immune-related genes and cell type scores between CR/PR (N = 7) and non-CR/PR patients (N = 7). (A–B) Expression of immune-related genes per pretreatment sample (BT) of response and non-response groups. (C) GSEA pathway enrichment analysis of different expressed genes between CR/PR and non-CR/PR patients. (D) Different cell type scores in per pretreatment sample of CR/PR and non-CR/PR patients. Each point in the boxplot represents for one sample. Whiskers show the minimum and maximum of all the data. The horizontal line in the box represents the median, and the top and bottom of each box indicate the 25th and 75th percentile. The significance for differences between CR/PR and non-CR/PR patients was tested using Wilcoxon’ s rank-sum test. Statistical tests were two sided.